Kurt J. Hilzinger - Dec 31, 2021 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Kurt J. Hilzinger
Stock symbol
HUM
Transactions as of
Dec 31, 2021
Transactions value $
$184,942
Form type
4
Date filed
1/4/2022, 08:38 AM
Previous filing
Oct 7, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 19.4K Dec 31, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $98.8K +212 +14.45% $465.85 1.68K Dec 31, 2021 Humana Common 212 Direct F2
transaction HUM Restricted Stock Units Award $86.2K +185 +1.67% $465.85 11.3K Dec 31, 2021 Humana Common 185 Direct F3
transaction HUM Restricted Stock Units Award $0 +412 $0.00 412 Jan 3, 2022 Humana Common 412 Direct F4
holding HUM Restricted Stock Units 22K Dec 31, 2021 Humana Common 22K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022.